Molecules 2011, 16
8108
3.6. General Procedure to Remove Boc-Protecting Group (Adapted from Reference [19])
To a mixture of AcOEt:HCl 3 mol L−1 1:1 (5 mL), N-Boc protected compound (1 mmol) was
added. The mixture was stirred at room temperature for 1 h. After that, the solvent was removed under
vacuum. The residue was dissolved in CH2Cl2 (10 mL) and washed with saturated NaHCO3 solution
(3 × 3 mL). Then, the organic layer was dried over MgSO4, filtered and concentrated to dryness under
vacuum. The product was obtained in quantitative yield without further purification.
4. Conclusions
In summary, we have described an efficient methodology to obtain (R)- and (S)-tert-butyl 2-(1-
hydroxyethyl)phenylcarbamates in enantiopure form (ee > 99%), using a kinetic resolution process
mediated by lipase as a biocatalyst. Both enantiomers can be employed in the preparation of
organochalcogenanes for further application in biological studies.
Acknowledgments
The authors thank CNPq, CAPES and FAPESP for their financial support.
References
1. Mugesh, G.; du Mont, W.-W.; Sies, H. Chemistry of biologically important synthetic
organoselenium compounds. Chem. Rev. 2001, 101, 2125-2179.
2. Ba, L.A.; Döring, M.; Jamier, V.; Jacob, C. Tellurium: An element with great biological potency
and potential. Org. Biomol. Chem. 2010, 8, 4203-4216.
3. Brabak, K.P.; Mugesh, G. Functional mimics of glutathione peroxidase bioinspired synthetic
antioxidants. Acc. Chem. Res. 2010, 43, 1408-1419.
4. Alberto, E.E.; do Nascimento, V.; Braga, A.L. Catalytic application of selenium and tellurium
compounds as glutathione peroxidase enzyme mimetics. J. Braz. Chem. Soc. 2010, 21, 2032-2041.
5. Piovan, L.; Alves, M.F.M.; Juliano, L.; Bromme, D.; Cunha, R.L.O.R.; Andrade, L.H. Structure-
activity relationships of hypervalent organochalcogenanes as inhibitors of cysteine cathepsins V
and S. Bioorg. Med. Chem. 2011, 19, 2009-2014.
6. Piovan, L.; Alves, M.F.M.; Juliano, L.; Bromme, D.; Cunha, R.L.O.R.; Andrade, L.H.
Chemoenzymatic synthesis of organoselenanium(IV) compounds and their evaluation as cysteine
proteases inhibitors. J. Braz. Chem. Soc. 2010, 21, 2108-2118.
7. Cunha, R.L.O.R.; Urano, M.E.; Chagas, J.R.; Almeida, P.C.; Bincoleto, C.; Tersariol, I.L.S.;
Comasseto, J.V. Tellurium-based cysteine inhibitors: Evaluation of novel organotellurium(IV)
compounds as inhibitors of human cathepsin B. Bioorg. Med. Chem. Lett. 2005, 15, 755-760.
8. Cunha, R.L.O.R.; Gouvêa, I.E.; Feitosa, G.P.V.; Alves, M.F.M.; Bromme, D.; Comasseto, J.V.;
Tersariol, I.L.S.; Juliano, L. Irreversible inhibition of human cathepsins B, L, S, and K by
hypervalent tellurium compounds. Biol. Chem. 2009, 390, 1205-1212.
9. Piovan, L.; Wu, L.; Zhang, Z.Y.; Andrade, L.H. Hypervalent organochalcogenanes as inhibitors
of protein tyrosine phosphatases. Org. Biomol. Chem. 2011, 9, 1347-1351.